Back to results
US 7,763,710 B2Granted
ALS-specific peptide composition
AssigneeAmorfix Life Sciences Ltd.
InventorNeil Cashman
Life of this patent
Estimating the term…
Abstract
The invention relates to a composition for eliciting an immune response in an animal to produce an antibody that binds selectively to an amyotrophic lateral sclerosis (ALS)-specific epitope.
Claims4
A composition for eliciting an immune response in an animal to produce an antibody that binds selectively to an amyotrophic lateral sclerosis (ALS)-specific epitope, the composition comprising an effective amount of the isolated ALS-specific epitope in admixture with a suitable diluent or carrier, wherein the ALS-specific epitope is an isolated peptide consisting of the amino acid sequence NPLSRKHGGPKDEE (SEQ ID NO:2).
Dependencies are inferred from the claim text.